Publication | Open Access

Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

Multicentre Phase 2MedicineMetronomic TherapyPathologyCancer TreatmentOncologyRadiation OncologyLung CancerMolecular Oncology